HBCU Legends dives into the pulse of HBCU sports—covering everything from breaking health news and prostate cancer awareness ...

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.

Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...

The aggressiveness of a cancer is based on several factors, including the tumor's grade and stage, and the cells' genetic ...

Joe Bidens cancer diagnosis has raised big questions about his health and future. At 82, the former president is battling ...

New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...

Prostate cancer (PCa) remains a leading cause of cancer-related mortality globally, with late-stage diagnoses contributing to ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date ... but similar survival outcomes when both groups had equal access to care.

EXCLUSIVE: A leading authority in prostate treatment and urology has given his insights on a condition that can affect 1 in 8 ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer ...

Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...